Cargando…

Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM

OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD...

Descripción completa

Detalles Bibliográficos
Autores principales: Venepalli, Neeta K, Shergill, Ardaman, Dorestani, Parvaneh, Boyd, Andrew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226400/
https://www.ncbi.nlm.nih.gov/pubmed/25452683
http://dx.doi.org/10.4137/CIN.S14032
_version_ 1782343617613922304
author Venepalli, Neeta K
Shergill, Ardaman
Dorestani, Parvaneh
Boyd, Andrew D
author_facet Venepalli, Neeta K
Shergill, Ardaman
Dorestani, Parvaneh
Boyd, Andrew D
author_sort Venepalli, Neeta K
collection PubMed
description OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD-9-CM and ICD-10-CM bridging methodology for retrospective analyses. BACKGROUND: While the transition to ICD-10-CM has been delayed until October 2015, its impact on cancer-related studies utilizing ICD-9-CM diagnoses has been inadequately explored. MATERIALS AND METHODS: Three high impact journals with broad national and international readerships were reviewed for cancer-related studies utilizing ICD-9-CM diagnoses codes in study design, methods, or results. Forward ICD-9-CM to ICD-10-CM mapping was performing using a translational methodology with the Motif web portal ICD-9-CM conversion tool. Backward mapping from ICD-10-CM to ICD-9-CM was performed using both Centers for Medicare and Medicaid Services (CMS) general equivalence mappings (GEMs) files and the Motif web portal tool. Generated ICD-9-CM codes were compared with the original ICD-9-CM codes to assess data accuracy and discontinuity. RESULTS: While both methods yielded additional ICD-9-CM codes, the CMS GEMs method provided incomplete coverage with 16 of the original ICD-9-CM codes missing, whereas the Motif web portal method provided complete coverage. Of these 16 codes, 12 ICD-9-CM codes were present in 2010 Illinois Medicaid data, and accounted for 0.52% of patient encounters and 0.35% of total Medicaid reimbursements. Extraneous ICD-9-CM codes from both methods (Centers for Medicare and Medicaid Services general equivalent mapping [CMS GEMs, n = 161; Motif web portal, n = 246]) in excess of original ICD-9-CM codes accounted for 2.1% and 2.3% of total patient encounters and 3.4% and 4.1% of total Medicaid reimbursements from the 2010 Illinois Medicare database. DISCUSSION: Longitudinal data analyses post-ICD-10-CM transition will require backward ICD-10-CM to ICD-9-CM coding, and data comparison for accuracy. Researchers must be aware that all methods for backward coding are not comparable in yielding original ICD-9-CM codes. CONCLUSIONS: The mandated delay is an opportunity for organizations to better understand areas of financial risk with regards to data management via backward coding. Our methodology is relevant for all healthcare-related coding data, and can be replicated by organizations as a strategy to mitigate financial risk.
format Online
Article
Text
id pubmed-4226400
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-42264002014-12-01 Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM Venepalli, Neeta K Shergill, Ardaman Dorestani, Parvaneh Boyd, Andrew D Cancer Inform Review OBJECTIVE: To quantify the impact of International Classification of Disease 10th Revision Clinical Modification (ICD-10-CM) transition in cancer clinical trials by comparing coding accuracy and data discontinuity in backward ICD-10-CM to ICD-9-CM mapping via two tools, and to develop a standard ICD-9-CM and ICD-10-CM bridging methodology for retrospective analyses. BACKGROUND: While the transition to ICD-10-CM has been delayed until October 2015, its impact on cancer-related studies utilizing ICD-9-CM diagnoses has been inadequately explored. MATERIALS AND METHODS: Three high impact journals with broad national and international readerships were reviewed for cancer-related studies utilizing ICD-9-CM diagnoses codes in study design, methods, or results. Forward ICD-9-CM to ICD-10-CM mapping was performing using a translational methodology with the Motif web portal ICD-9-CM conversion tool. Backward mapping from ICD-10-CM to ICD-9-CM was performed using both Centers for Medicare and Medicaid Services (CMS) general equivalence mappings (GEMs) files and the Motif web portal tool. Generated ICD-9-CM codes were compared with the original ICD-9-CM codes to assess data accuracy and discontinuity. RESULTS: While both methods yielded additional ICD-9-CM codes, the CMS GEMs method provided incomplete coverage with 16 of the original ICD-9-CM codes missing, whereas the Motif web portal method provided complete coverage. Of these 16 codes, 12 ICD-9-CM codes were present in 2010 Illinois Medicaid data, and accounted for 0.52% of patient encounters and 0.35% of total Medicaid reimbursements. Extraneous ICD-9-CM codes from both methods (Centers for Medicare and Medicaid Services general equivalent mapping [CMS GEMs, n = 161; Motif web portal, n = 246]) in excess of original ICD-9-CM codes accounted for 2.1% and 2.3% of total patient encounters and 3.4% and 4.1% of total Medicaid reimbursements from the 2010 Illinois Medicare database. DISCUSSION: Longitudinal data analyses post-ICD-10-CM transition will require backward ICD-10-CM to ICD-9-CM coding, and data comparison for accuracy. Researchers must be aware that all methods for backward coding are not comparable in yielding original ICD-9-CM codes. CONCLUSIONS: The mandated delay is an opportunity for organizations to better understand areas of financial risk with regards to data management via backward coding. Our methodology is relevant for all healthcare-related coding data, and can be replicated by organizations as a strategy to mitigate financial risk. Libertas Academica 2014-11-09 /pmc/articles/PMC4226400/ /pubmed/25452683 http://dx.doi.org/10.4137/CIN.S14032 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Review
Venepalli, Neeta K
Shergill, Ardaman
Dorestani, Parvaneh
Boyd, Andrew D
Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title_full Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title_fullStr Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title_full_unstemmed Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title_short Conducting Retrospective Ontological Clinical Trials in ICD-9-CM in the Age of ICD-10-CM
title_sort conducting retrospective ontological clinical trials in icd-9-cm in the age of icd-10-cm
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226400/
https://www.ncbi.nlm.nih.gov/pubmed/25452683
http://dx.doi.org/10.4137/CIN.S14032
work_keys_str_mv AT venepallineetak conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm
AT shergillardaman conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm
AT dorestaniparvaneh conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm
AT boydandrewd conductingretrospectiveontologicalclinicaltrialsinicd9cmintheageoficd10cm